UltraSight
UltraSight is an Israeli AI-powered medical imaging startup that enables non-expert users to perform diagnostic-quality cardiac ultrasound examinations through real-time AI guidance.
Visit WebsiteCompany Overview
UltraSight develops AI technology that guides untrained users through cardiac ultrasound examinations in real-time, democratizing access to cardiac diagnostics. The AI system provides visual and audio guidance to help operators position the ultrasound probe correctly, acquire diagnostic-quality images, and interpret results without requiring years of specialized training.
The technology received FDA clearance and is deployed in settings where trained sonographers are unavailable, including rural clinics, emergency rooms, and remote locations. The platform integrates with standard portable ultrasound devices.
Dual-use relevance is high: AI-guided medical imaging enables both civilian healthcare access in underserved areas and military field medicine applications. Combat medics and field personnel can perform cardiac assessments without specialist training, critical for battlefield trauma assessment, forward surgical teams, and austere medical environments.
Dual-Use Assessment
AI-guided cardiac ultrasound enables both civilian healthcare democratization and military field medicine cardiac assessment by non-specialist personnel.
Key Technologies
- Real-time AI guidance for ultrasound probe positioning
- Computer vision for cardiac image quality assessment
- Audio and visual operator guidance system
- Portable ultrasound device integration
- Automated diagnostic image acquisition and interpretation
Use Cases & Applications
- Enabling cardiac diagnostics in rural and underserved civilian areas
- Military combat medic cardiac assessment in field conditions
- Emergency room rapid cardiac screening by non-specialists
- Forward surgical team diagnostic support
- Remote telemedicine-guided cardiac examination
Strategic Value to U.S.-Israel Alliance
AI-guided medical imaging technology critical for military field medicine and civilian healthcare access expansion.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.